GenomeWeb

gonorrhea

Apr 08, 2021

CLIA Waiver in Hand, Binx Health Targeting Retailers, Urgent Care Centers With STI Tests

Premium

Binx Health said that when it received FDA CLIA waiver, it already had a strategic partner for sales of its POC platform and chlamydia and gonorrhea tests.

Apr 06, 2021

CARB-X Commits up to $13.8M to Novel Microdevices for Point-of-Care STI Test

Novel Microdevices is developing a portable, sample-to-answer instrument that is designed to perform molecular testing on untreated patient samples.

Mar 30, 2021

Binx Health Chlamydia and Gonorrhea Test CLIA Waived

The 30-minute test can be used on samples from males and females in settings operating under a CLIA certificate of waiver.

Sep 09, 2020

Visby Medical Takes on STI, COVID-19 Testing With Single-Use PCR Machine

Premium

The company is currently working on multiple infectious disease products, including a panel for sexually transmitted infections and one for SARS-CoV-2.

Aug 05, 2020

Visby Medical Gonorrhea Test Wins $19M AMR Diagnostic Competition

The PCR diagnostic device is a palm-size, single-use, disposable device that detects N. gonorrhoeae and determines if it's susceptible to an antibiotic.

Jun 16, 2020

Roche, SpeeDx Partner to Expand Access to Antibiotic Resistance Tests

Roche will have non-exclusive access to SpeeDx's existing tests and technology to enable expansion of diagnostic products for antibiotic resistance in STIs.

Apr 30, 2020

FDA Provides Second Clearance for Binx MDx Platform

The FDA cleared the point-of-care Binx io platform for the detection of chlamydia and gonorrhea in male urine specimens.

Feb 11, 2020

New York State Approves Enzo Biochem STI Tests on GenFlex Platform

The GenFlex is a sample-to-result molecular diagnostic platform that includes sample collection, processing, amplification, and detection, the company said.

Nov 19, 2019

Rheonix Submits MDx System, Triplex Sexually Transmitted Infections Test to FDA

The Ithaca, New York-based firm has submitted its molecular diagnostic instrument along with a test to detect chlamydia, gonorrhea, and trichomonas.

Nov 07, 2019

SpeeDx, QuantuMDx Collaborate with FIND on POC Molecular Diagnostics for STIs

FIND also announced support for projects from Axxin and DNC Dx for point-of-care detection of sexually transmitted infections.

Breaking News

The Scan

A Few, as Expected

The US Centers for Disease Control and Prevention has identified a small group of breakthrough COVID-19 cases, the Wall Street Journal reports.

For the Unknown Soldiers

The New York Times reports that the US Department of Defense is to use genetic genealogy approaches to identify the remains of unknown soldiers.

Prep for the Next One

Vox and Nature discuss the importance of preparing for the next pandemic.

Nature Papers Compare CtDNA Assays, Examine Lettuce Domestication, More

In Nature this week: comparison of five circulating tumor DNA assays, resequencing analysis of lettuce gives insight into its domestication, and more.

Menu